# SARCULATOR vs ASCO Guidelines

The clearest difference is rating: ASCO Guidelines at 4.8 against SARCULATOR's 4.3. ASCO Guidelines also leads on ratings volume (257 vs 3) and iOS requirement (10.0 vs 13.0). On price, update cadence, ads and in-app purchases there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ASCO Guidelines holds the better App Store score, 4.8 against 4.3. That said, the two scores are not equally well evidenced: ASCO Guidelines has 257 ratings behind it against 3, so its average is the more settled of the two.

SARCULATOR ships an update every 7 months, ASCO Guidelines every 5 months. The most recent releases landed on September 21, 2026 and September 23, 2026 respectively.

## The numbers

| Metric | SARCULATOR | ASCO Guidelines |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [4.3 (3 ratings)](https://appshunter.io/ios/app/sarculator/id1052119173/reviews) | **[4.8 (257 ratings)](https://appshunter.io/ios/app/asco-guidelines/id1238827183/reviews)** |
| Number of ratings | 3 | **257** |
| Positive reviews | — | 57.1% of reviews |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 7 months | **Every 5 months** |
| Monetization | Free | Free |
| Size | 26 MB | 411 MB |
| Requires iOS | 13.0 | **10.0** |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 12+ |
| Developer | [DIGITAL FOREST SRL](https://appshunter.io/developer/581246108) | [American Society of Clinical Oncology](https://appshunter.io/developer/1513043539) |

## What reviewers say

### SARCULATOR

[App page](https://appshunter.io/ios/app/sarculator/id1052119173)

This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.

**Highlights:** Predictive models for sarcoma patients, Estimates 5-year overall survival, Estimates 5-year disease-free survival, Estimates 10-year overall survival, Estimates cumulative incidence of distant metastasis, Informative tool for physicians

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


### ASCO Guidelines

[App page](https://appshunter.io/ios/app/asco-guidelines/id1238827183)

Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.

**Highlights:** Guideline recommendations for cancer care, Interactive treatment decision tools, Supports healthcare providers, Informs patients and caregivers, Covers various cancer types, Regularly updated content

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is SARCULATOR free?

SARCULATOR is free to download, with no in-app purchases.

### Is ASCO Guidelines free?

ASCO Guidelines is free to download, with no in-app purchases.

### Which has better reviews, SARCULATOR or ASCO Guidelines?

ASCO Guidelines is rated higher. SARCULATOR averages 4.3 out of 5 from 3 ratings, while ASCO Guidelines averages 4.8 from 257 ratings.

### Do SARCULATOR or ASCO Guidelines have ads?

Neither SARCULATOR nor ASCO Guidelines shows ads.

### Which is updated more often, SARCULATOR or ASCO Guidelines?

SARCULATOR ships an update every 7 months, and ASCO Guidelines every 5 months. Most recently, SARCULATOR was updated on September 21, 2026 and ASCO Guidelines on September 23, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*